Discover
CORT
Corcept Therapeutics Incorporated
121.19
2 x 112.22
2 x 128.66
bid
ask
+
2.65
2.24%
2 @ 05:34 PM
121.19 +0.00 (0.00%)
| Ytd | 248.25% | |
| 1y | 37.15% |
117.58
day range
122.34
32.15
52 week range
123.57
| Open | 118.00 | Prev Close | 118.54 | Low | 117.58 | High | 122.34 | Mkt Cap | 13.10B |
| Vol | 624.21K | Avg Vol | 1.29M | EPS | 0.46 | P/E | 263.46 | Forward P/E | 27.53 |
| Beta | 0.40 | Short Ratio | 10.68 | Inst. Own | 76.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 115.12 | 200-d Avg | 70.68 | 1yr Est | 141.00 |
| Income Statement | |||
| Total Revenue | 256.15M | ||
| Revenues (USD) | 256.15M | ||
| Cost of Revenue | 4.06M | ||
| Gross Profit | 252.09M | ||
| Operating Expenses | 210.79M | ||
| Research and Development Expense | 53.89M | ||
| Selling, General and Administrative Expense | 156.90M | ||
| Operating Income | 41.30M | ||
| Interest Expense | -4.63M | ||
| Income Tax Expense | 2.94M | ||
| Net Income | 42.14M | ||
| Net Income Common Stock | 42.14M | ||
| Net Income Common Stock (USD) | 42.14M | ||
| Consolidated Income | 42.99M | ||
| Net Income to Non-Controlling Interests | 846.00K | ||
| Earnings per Basic Share | 0.40 | ||
| Earnings per Basic Share (USD) | 0.40 | ||
| Earnings per Diluted Share | 0.36 | ||
| Earning Before Interest & Taxes (EBIT) | 40.45M | ||
| Earning Before Interest & Taxes (USD) | 40.45M | ||
| Weighted Average Shares | 105.38M | ||
| Weighted Average Shares Diluted | 118.39M | ||
| Balance Sheet | |||
| Cash and Equivalents | 111.04M | ||
| Cash and Equivalents (USD) | 111.04M | ||
| Investments | 433.61M | ||
| Investments Current | 197.16M | ||
| Investments Non-Current | 236.45M | ||
| Trade and Non-Trade Receivables | 76.92M | ||
| Current Assets | 439.68M | ||
| Property, Plant & Equipment Net | 11.99M | ||
| Total Assets | 888.70M | ||
| Debt Current | 1.92M | ||
| Total Debt | 9.42M | ||
| Current Liabilities | 153.80M | ||
| Debt Non-Current | 7.50M | ||
| Total Liabilities | 182.93M | ||
| Accumulated Retained Earnings (Deficit) | 654.61M | ||
| Accumulated Other Comprehensive Income | 436.00K | ||
| Shareholders Equity | 705.78M | ||
| Shareholders Equity (USD) | 705.78M | ||
| Assets Non-Current | 449.03M | ||
| Total Debt (USD) | 9.42M | ||
| Inventory | 32.14M | ||
| Liabilities Non-Current | 29.12M | ||
| Trade and Non-Trade Payables | 14.91M | ||
| Tax Assets | 178.68M | ||
| Tax Liabilities | 15.49M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 863.00K | ||
| Net Cash Flow from Financing | -2.04M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.30M | ||
| Capital Expenditure | -2.53M | ||
| Issuance (Purchase) of Equity Shares | -2.04M | ||
| Net Cash Flow from Investing | -29.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -26.71M | ||
| Net Cash Flow from Operations | 33.54M | ||
| Effect of Exchange Rate Changes on Cash | 37.00K | ||
| Share Based Compensation | 29.42M | ||